中文 | English
Return
Total: 153 , 1/16
Show Home Prev Next End page: GO
MeSH:(Cyclophosphamide/*administration )

1.An Unusual Case of Spontaneous Remission of Hodgkin's Disease after a Single Cycle of COPP-ABV Chemotherapy Followed by Infectious Complications.

Seungmin BANG ; June Won CHEONG ; Woo Ick YANG ; Jee Sook HAHN

Yonsei Medical Journal 2005;46(3):425-430

2.Effects of Different Dose of Cyclophosphamide on Peripheral Blood Cells of Normal ICR Mice.

Guo-Lin XIONG ; Shuang XING ; Xing SHEN ; Meng YANG ; Zu-Yin YU

Journal of Experimental Hematology 2015;23(5):1493-1496

3.Oral combination chemotherapy of 5'-deoxy-5-fluorouridine (furtulon) and cyclophosphamide for advanced breast cancer.

Bing-he XU ; Ying-juan ZHANG ; Xiao ZHENG ; Qing WU ; Xiao-ting WU

Chinese Journal of Oncology 2003;25(3):282-284

4.Establishment of an animal model of azoospermia in male mice.

Xun-bin HUANG ; Hong-gang LI

National Journal of Andrology 2007;13(2):147-149

6.Clinical study of COAD-B regimen in treatment of patients with relapsed/refractory non-Hodgkin lymphoma.

Ming-hui LI ; Yu-fu LI ; Qing-song YIN ; Rui-hua MI ; Lin CHEN ; Jian-wei DU ; Xu-dong WEI

Chinese Journal of Hematology 2013;34(10):857-861

7.HER2 over-expression and response to different chemotherapy regimens in breast cancer.

Jin ZHANG ; Yan LIU

Journal of Zhejiang University. Science. B 2008;9(1):5-9

10.The Effect of Botulinum Toxin and Resiniferatoxin on the Detrusor Overactivity Induced by Cyclophosphamide in Rat Bladder.

San Wook KIM ; Kang Soo SHIM ; Jeong Gu LEE

Korean Journal of Urology 2006;47(1):47-54

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 153 , 1/16 Show Home Prev Next End page: GO